Valneva SE (France) Top Management
VLA Stock | EUR 1.83 0.01 0.54% |
Valneva SE employs about 762 people. The company is managed by 10 executives with a total tenure of roughly 1778 years, averaging almost 177.0 years of service per executive, having 76.2 employees per reported executive. Analysis of Valneva SE's management performance can provide insight into the company performance.
Dipal Patel Insider Chief Board |
Frederic Jacotot Insider Gen IP |
Valneva |
Valneva SE Management Team Effectiveness
The company has return on total asset (ROA) of (0.185) % which means that it has lost $0.185 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.8614) %, meaning that it generated substantial loss on money invested by shareholders. Valneva SE's management efficiency ratios could be used to measure how well Valneva SE manages its routine affairs as well as how well it operates its assets and liabilities.Valneva SE Workforce Comparison
Valneva SE is rated first in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 950. Valneva SE totals roughly 762 in number of employees claiming about 80% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.17 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06. Valneva SE Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Valneva SE Price Series Summation is a cross summation of Valneva SE price series and its benchmark/peer.
Valneva SE Notable Stakeholders
A Valneva SE stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Valneva SE often face trade-offs trying to please all of them. Valneva SE's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Valneva SE's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Dipal Patel | Chief Board | Profile | |
Frederic Jacotot | Gen IP | Profile | |
Laetitia BachelotFontaine | VP Relations | Profile | |
JuanCarlos MD | Chief Board | Profile | |
Thomas Lingelbach | Pres Board | Profile | |
Gerald Strohmaier | VP Resource | Profile | |
Franck MBA | Chief Gen | Profile | |
Peter Buhler | CFO Member | Profile | |
Perry Celentano | Interim Officer | Profile | |
Joshua Drumm | VP Relations | Profile |
About Valneva SE Management Performance
The success or failure of an entity such as Valneva SE often depends on how effective the management is. Valneva SE management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Valneva management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Valneva management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Valneva SE, a specialty vaccine company, focused on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Valneva SE was incorporated in 1999 and is headquartered in Saint-Herblain, France. VALNEVA operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 700 people.
Please note, the presentation of Valneva SE's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Valneva SE's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Valneva SE's management manipulating its earnings.
Valneva SE Workforce Analysis
Traditionally, organizations such as Valneva SE use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Valneva SE within its industry.Valneva SE Manpower Efficiency
Return on Valneva SE Manpower
Revenue Per Employee | 456.8K | |
Revenue Per Executive | 34.8M | |
Net Loss Per Employee | 96.4K | |
Net Loss Per Executive | 7.3M |
Complementary Tools for Valneva Stock analysis
When running Valneva SE's price analysis, check to measure Valneva SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Valneva SE is operating at the current time. Most of Valneva SE's value examination focuses on studying past and present price action to predict the probability of Valneva SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Valneva SE's price. Additionally, you may evaluate how the addition of Valneva SE to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |